Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
Clinical trial NCT04324164 · RECRUITING
Trial details
- NCT number
- NCT04324164
- Sponsor
- Hunan Province Tumor Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-24
- Primary completion
- 2025-12-24
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.